All‐cause mortality (RR) Range of · patients with chronic heart failure with preserved ejection fraction
Angiotensin receptor neprilysin inhibitors (ARNIs) leads to lower all‐cause mortality (RR) Range of compared with usual care (high certainty).
1 finding from 1 review
Cardiovascular mortality · patients with chronic heart failure with preserved ejection fraction
Angiotensin receptor neprilysin inhibitors (ARNIs) showed no clear difference in cardiovascular mortality (RR) Median compared with usual care (moderate certainty).
1 finding from 1 review
Cancer‐related mortality at maximal · people with unprovoked VTE
Extensive tests showed no clear difference in cancer‐related mortality2 compared with tests at the physician's discretion (low certainty).
1 finding from 1 review
Perinatal mortality · Children (as neonate, child, adult) of women with GDM
1 finding from 1 review
Death or serious morbidity composite · Children (as neonate, child, adult) of women with GDM
Intensity of glycaemic control for women with gestational diabetes… showed no clear difference in composite of mortality or serious morbidity (as defined by trial) compared with less‐tight glycaemic targets (child (as neonate, child, adult)… (low certainty).
1 finding from 1 review
All‐cause mortality · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stroke‐related mortality · asymptomatic carotid stenosis
Antihypertensive agent showed no clear difference in stroke‐related mortality (not reported) compared with placebo (low certainty).
1 finding from 1 review
Perinatal mortality · women in established labour and their babies.
It is very uncertain whether intermittent ausculation of fetal heart rate in labour for fetal… changes perinatal mortality compared with routine Pinard (outcomes (very low certainty).
1 finding from 1 review
Mortality due to any cause · children with sickle cell anaemia and microalbuminuria
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events—all‐cause mortality · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Death or serious morbidity composite · women in established labour and their babies.
1 finding from 1 review
All‐cause short‐term mortality: at intensive care unit · adults with cardiogenic shock
It is very uncertain whether dopamine‐milrinone changes all‐cause short‐term mortality: at intensive care unit compared with dopamine‐dobutamine (very low certainty).
1 finding from 1 review
Mortality and morbidity prior to discharge (Neonatal intensive care admissions) · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in mortality and morbidity prior to discharge (Neonatal intensive care… compared with placebo (low certainty).
1 finding from 1 review
Serious maternal morbidity or death · women with prelabour rupture of membranes at term (37 weeks' gestation or later)
1 finding from 1 review
All‐cause mortality · pulmonary arterial hypertension
1 finding from 1 review
All‐cause mortality · pulmonary arterial hypertension
Prostacyclin probably leads to lower mortality compared with control (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
The intervention showed no clear difference in mortality (low certainty).
1 finding from 1 review
Total mortality · adults with hypertension (patients with atrial fibrillation, congestive heart failure, pre‐eclampsia or pulmonary hypertension were…
Aspirin showed no clear difference in total mortality compared with placebo (low certainty).
1 finding from 1 review
Total mortality · Men and non‐pregnant women ≥ 18 years old with essential hypertension
1 finding from 1 review
Total mortality · Men and non‐pregnant women ≥ 18 years old with essential hypertension
Naltrexone/bupropion showed no clear difference in total mortality compared with placebo (moderate certainty).
1 finding from 1 review